Preferred Label : drug monitoring;
MeSH definition : The process of observing, recording, or detecting the effects of a chemical substance
administered to an individual therapeutically or diagnostically.;
MeSH synonym : monitoring, drug;
CISMeF acronym : TDM;
MeSH hyponym : therapeutic drug monitoring; Drug Monitoring, Therapeutic; Monitoring, Therapeutic Drug;
Wikipedia link : https://en.wikipedia.org/wiki/Therapeutic drug monitoring;
Origin ID : D016903;
UMLS CUI : C0085421;
Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- Metaterm(s)
- Ne pas confondre avec
- Record concept(s)
- See also
- Semantic type(s)
- UMLS correspondences (same concept)
The process of observing, recording, or detecting the effects of a chemical substance
administered to an individual therapeutically or diagnostically.
PUBLIÉ LE 17/05/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-04-2023-au-11-05-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-16-03-2023-au-13-04-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 31/03/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-10-02-2023-au-16-03-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 27/02/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-01-2023-au-16-02-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/tableau-atu-rtu/opdivo-nivolumab-solution-a-diluer-pour-perfusion-yervoy-ipilimumab-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
guidelines for drug use
Nivolumab
Ipilimumab/Nivolumab Regimen
Ipilimumab
Antineoplastic Agents, Immunological
Malignant Pleural Mesothelioma
disease progression
Progressive Neoplastic Disease
infusions, intravenous
continuity of patient care
drug monitoring
carcinoma, non-small-cell lung
melanoma
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIIB Cutaneous Melanoma AJCC v7
---
https://ansm.sante.fr/dossiers-thematiques/covid-19-dispositif-renforce-de-pharmacovigilance-et-daddictovigilance
2023
false
false
false
France
French
drug monitoring
scientific and technical information
drug information
Drug-Related side effects and adverse reactions
pharmacovigilance
substance causing dependence
public health surveillance
substance-related disorders
COVID-19
---
PUBLIÉ LE 25/01/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-22-12-2022-au-19-01-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-14-04-2023-au-8-06-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 18/02/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-28-01-2022-au-10-02-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 04/03/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-11-02-2022-au-24-02-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 18/03/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-02-2022-au-10-03-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
brachial plexus neuritis
anemia, hemolytic, autoimmune
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 01/04/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-11-03-2022-au-24-03-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/dossiers-thematiques/covid-19-vaccins/covid-19-suivi-hebdomadaire-des-cas-deffets-indesirables-des-vaccins
2022
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
drug monitoring
drug information
Drug-Related side effects and adverse reactions
france
vaccination
ChAdOx1 nCoV-19
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 27/12/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-11-2022-au-22-12-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-21-10-2022-au-24-11-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-30-09-2022-au-20-10-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
menorrhagia
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-2-09-2022-au-29-09-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-22-07-2022-au-08-09-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 15/04/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-03-2022-au-07-04-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
vasculitis
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 31/05/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-06-05-2022-au-23-05-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 01/08/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-17-06-2022-au-21-07-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
pericarditis
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://www.ansm.sante.fr/actualites/premier-point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
pneumonia, viral
coronavirus infections
pandemics
viral vaccines
coronavirus infections
COVID-19
COVID-19 Vaccines
---
https://www.ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://www.ansm.sante.fr/actualites/acetate-de-nomegestrol-lutenyl-et-generiques-acetate-de-chlormadinone-luteran-et-generiques-et-risque-de-meningiome-recommandations-dutilisation-et-de-suivi-des-patientes
2021
false
false
false
France
French
guidelines for drug use
continuity of patient care
drug monitoring
Drug-Related side effects and adverse reactions
nomegestrol acetate
nomegestrol
chlormadinone
chlormadinone acetate
risk
meningioma
risk assessment
meningioma
chlormadinone acetate
megestrol
norpregnadienes
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-1
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-2
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
aged
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-3
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-4
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-5
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-6
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-7
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
http://www.lecofer.org/item-objectifs-0-29-0.php
2021
France
educational course
adulthood
adrenal cortical hormone, nos
drug monitoring
Child
drug, nos
Angiomyxoma
Prescription Drug Monitoring Programs
child, nos
Child
glucocorticoids
anti-inflammatory agents, non-steroidal
adult
child
Child
Adult
corticoids
Child
Adult
filing
prescription, nos
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-8
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-9
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-10
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/uploads/2021/03/16/20210315-atuc-bamlanivimab-etesevimab-put-2.pdf
2021
false
false
false
France
French
drug therapy, combination
guideline
health occupations
professional role
risk management
continuity of patient care
drug monitoring
infusions, intravenous
pharmacovigilance
information dissemination
drug prescriptions
Therapy cessation
adult
aged
antibodies, monoclonal, humanized
Etesevimab
Bamlanivimab
spike glycoprotein, coronavirus
adverse drug reaction reporting systems
bamlanivimab
bamlanivimab
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
COVID-19
COVID-19
antibodies, monoclonal, humanized
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-11
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/dossiers-thematiques/covid-19-suivi-hebdomadaire-des-cas-deffets-indesirables-des-vaccins
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
Publié le 02/04/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-19-03-2021-au-25-03-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
ChAdOx1 nCoV-19
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
Publié le 09/04/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-26-03-2021-au-01-04-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
ChAdOx1 nCoV-19
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-02-04-2021-au-08-04-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
covid-19, viral vector, non-replicating
ChAdOx1 nCoV-19
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-09-04-2021-au-15-04-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
ChAdOx1 nCoV-19
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
Publié le 30/04/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-16-04-2021-au-22-04-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-23-04-2021-au-29-04-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
Publié le 17/05/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-30-04-2021-au-06-05-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
Publié le 21/05/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-07-05-2021-au-13-05-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
Publié le 28/05/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-14-05-2021-au-20-05-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/informations-de-securite/vaxzevria-covid-19-vaccine-astrazeneca-risque-de-thromboses-en-association-avec-une-thrombocytopenie-mise-a-jour-de-linformation
2021
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
thrombosis
continuity of patient care
drug monitoring
thrombocytopenia
thrombosis
vaccination
covid-19, viral vector, non-replicating
Drug Induced Thrombocytopenia
adenoviruses, simian
thrombotic thrombocytopenic syndrome
ChAdOx1 nCoV-19
viral vaccines
coronavirus infections
coronavirus infections
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
Publié le 04/06/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-21-05-2021-au-27-05-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-28-05-2021-au-03-06-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
myocarditis
pericarditis
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 18/06/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-04-06-2021-au-10-06-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-12
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
viral vaccines
coronavirus infections
mRNA vaccine
adenoviruses, simian
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 16/07/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-06-2021-au-08-07-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 23/07/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-09-07-2021-au-15-07-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 30/07/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-16-07-2021-au-22-07-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 06/08/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-23-07-2021-au-29-07-2021
2021
false
false
false
France
French
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
drug information
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 27/08/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-30-07-2021-au-19-08-2021
2021
false
false
false
France
French
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 13/09/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-20-08-2021-au-02-09-2021
2021
false
false
false
France
French
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Covid-19 vaccines
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 24/09/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-03-09-2021-au-16-09-2021
2021
false
false
false
France
French
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 08/10/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-17-09-2021-au-30-09-2021
2021
false
false
false
France
French
brachial plexus neuritis
hypertension
myocarditis
pericarditis
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/tableau-atu-rtu/nplate-250-microgrammes-500-microgrammes-poudre-et-solvant-ou-solution-injectable
2021
false
false
false
France
French
guidelines for drug use
continuity of patient care
drug monitoring
romiplostim
romiplostim
romiplostim
myelodysplastic syndromes
thrombocytopenia
adult
injections, subcutaneous
---
https://ansm.sante.fr/tableau-atu-rtu/opdivo-10-mg-ml-solution-a-diluer-pour-perfusion-2
2021
false
false
false
France
French
infusions, intravenous
guidelines for drug use
continuity of patient care
drug monitoring
adult
melanoma
Antineoplastic Agents, Immunological
Nivolumab
nivolumab
---
PUBLIÉ LE 22/10/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-01-10-2021-au-14-10-2021
2021
false
false
false
France
French
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
arthritis, rheumatoid
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/suivi-des-effets-indesirables-des-medicaments-utilises-dans-la-prise-en-charge-de-la-covid-19-en-date-du-08-10-2021
2021
false
false
false
France
French
pharmacovigilance
drug monitoring
COVID-19
drug information
tocilizumab
lopinavir-ritonavir drug combination
hydroxychloroquine
dexamethasone
remdesivir
antiviral agents
glucocorticoids
cytokine storm syndrome in COVID-19
Cytokine Release Syndrome
---
PUBLIÉ LE 05/11/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-15-10-2021-au-28-10-2021
2021
false
false
false
France
French
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
myocarditis
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 19/11/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-29-10-2021-au-11-11-2021
2021
false
false
false
France
French
creutzfeldt-jakob syndrome
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/tableau-atu-rtu/mylotarg-5-mg-poudre-pour-solution-a-diluer-pour-perfusion
2021
false
false
false
France
French
Gemtuzumab
gemtuzumab ozogamicin
guidelines for drug use
continuity of patient care
drug monitoring
leukemia, myeloid, acute
adult
child
recurrence
Recurrent Childhood Acute Myeloid Leukemia
Recurrent Adult Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
CD33 Positive
antineoplastic combined chemotherapy protocols
infusions, intravenous
Antineoplastic Agents, Immunological
gemtuzumab ozogamicin
---
PUBLIÉ LE 03/12/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-12-11-2021-au-25-11-2021
2021
false
false
false
France
French
epidermal necrolysis, toxic
mRNA Vaccine
mRNA Vaccines
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
https://ansm.sante.fr/actualites/surveillance-des-vaccins-contre-la-covid-19-que-retenir-pres-dun-an-apres-le-debut-de-la-campagne-vaccinale
2021
false
false
false
France
French
drug information
COVID-19 Vaccines
vaccination
COVID-19
drug monitoring
pharmacovigilance
COVID-19 Vaccines
mRNA Vaccine
---
PUBLIÉ LE 21/12/2021
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-26-11-21-au-09-12-2021
2021
false
false
false
France
French
mRNA Vaccine
menstruation disturbances
vaccination
sarcoidosis
Still's disease
mRNA Vaccines
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 07/01/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-10-12-2021-au-30-12-2021
2021
false
false
false
France
French
mRNA Vaccine
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 21/01/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-31-12-2021-au-13-01-2022
2021
false
false
false
France
French
mRNA Vaccine
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
PUBLIÉ LE 04/02/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-14-01-2022-au-27-01-2022
2021
false
false
false
France
French
mRNA Vaccine
myocardial infarction
deep vein thrombosis
pulmonary embolism
pseudopolyarthritis, rhizomelic
ChAdOx1 nCoV-19
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines
---
http://www.theses.fr/2021AIXM0256
2021
France
dissertations, academic
behavior
behavior, nos
drug abuse
substance-related disorders
drug monitoring
drug abuse, nos
---
https://ansm.sante.fr/actualites/medicaments-utilises-chez-les-patients-atteints-de-la-covid-19-une-surveillance-renforcee-des-effets-indesirables
2020
false
false
false
France
French
pharmacovigilance note
drug monitoring
Off-Label use
lopinavir-ritonavir drug combination
hydroxychloroquine
antiviral agents
cardiovascular diseases
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
pneumonia, viral
coronavirus infections
pandemics
COVID-19
COVID-19
---
https://www.anses.fr/fr/system/files/ANMV-Ra-Pharmacovigilance2019.pdf
2020
France
technical report
drug monitoring
albumin/globulin ratio
product surveillance, postmarketing
Annual Report
drug, nos
veterinary drugs
inlets
Intercondylar fracture of the humerus
bays
research report
---
https://sfpt-fr.org/images/documents/STP/Recommandations_STP_ANRS_AC43_Pharmacologie_v2_26_03_20.pdf
2020
false
false
false
France
coronavirus infections
pneumonia, viral
lopinavir-ritonavir drug combination
guideline
hydroxychloroquine
drug monitoring
pandemics
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
COVID-19
---
Wizvi
https://apps.apple.com/fr/app/doctorpocket/id897050747
https://play.google.com/store/apps/details?id=com.application.doctorpocket4
https://www.wizvi.com/
https://is2-ssl.mzstatic.com/image/thumb/Purple113/v4/49/ce/be/49cebec7-eab4-a942-4a97-e65398a46e52/AppIcon-0-1x_U007emarketing-0-85-220-0-4.png/246x0w.png
3.1.0
3.1.0
2019-06-05
2019-05-23
https://is2-ssl.mzstatic.com/image/thumb/Purple113/v4/1a/58/a4/1a58a4fa-45ec-3cb2-b4cd-4551330896a1/pr_source.png/300x0w.png
https://is5-ssl.mzstatic.com/image/thumb/Purple113/v4/f5/4b/89/f54b8974-96f5-4f09-95ae-1a64eb7c66a1/pr_source.png/300x0w.png
https://is4-ssl.mzstatic.com/image/thumb/Purple123/v4/aa/73/42/aa734283-7427-737d-835c-a05a68fd3fcf/pr_source.png/300x0w.png
https://is2-ssl.mzstatic.com/image/thumb/Purple123/v4/c0/a1/f8/c0a1f88a-b718-1864-f5f6-38990d2d88ad/pr_source.png/300x0w.png
https://is3-ssl.mzstatic.com/image/thumb/Purple123/v4/68/f0/75/68f07569-134f-7940-dd48-0efdb0cfaae0/pr_source.png/300x0w.png
https://is1-ssl.mzstatic.com/image/thumb/Purple113/v4/6f/cd/a8/6fcda855-dbe0-1e62-2385-d112515eb75a/pr_source.png/300x0w.png
https://is1-ssl.mzstatic.com/image/thumb/Purple123/v4/30/be/5a/30be5a5d-1ca1-2cef-3c7e-f6604900a014/pr_source.png/300x0w.png
https://is5-ssl.mzstatic.com/image/thumb/Purple113/v4/f5/11/6d/f5116ddd-09e5-39a6-adf2-c57ace42a055/pr_source.png/300x0w.png
https://is5-ssl.mzstatic.com/image/thumb/Purple113/v4/4b/59/5b/4b595b85-3136-9248-9a47-d4496034c5fd/pr_source.png/230x0w.png
Doktorpocket
false
false
false
appointments and schedules
drug prescriptions
drug monitoring
---
My eReport
https://apps.apple.com/fr/app/my-ereport/id806103319
https://play.google.com/store/apps/details?id=fr.evedrug&hl=fr
https://www.evedrug.eu/myereport.php
https://www.myereport.eu/
https://is3-ssl.mzstatic.com/image/thumb/Purple91/v4/b7/b7/4b/b7b74b77-95bd-c48f-67ba-45ac3925d674/mzl.inczfanh.png/246x0w.png
1.12
2.9.3
2018-01-16
2017-04-20
https://is4-ssl.mzstatic.com/image/thumb/Purple62/v4/d8/1c/5f/d81c5f49-3048-6a89-e7f0-3d187dcdee51/mzl.wucyezja.png/300x0w.png
eVeDrug
false
false
false
Drug-Related side effects and adverse reactions
adverse drug reaction reporting systems
drug monitoring
Drug-Related side effects and adverse reactions
---
https://hal.archives-ouvertes.fr/hal-01862281
2019
false
false
false
France
fluorouracil
fluorouracil
continuity of patient care
antimetabolites, antineoplastic
antimetabolites, antineoplastic
antimetabolites, antineoplastic
neoplasms
dose-response relationship, drug
practice guideline
fluorouracil
drug monitoring
---
https://ansm.sante.fr/informations-de-securite/esmya-r-acetate-dulipristal-5-mg-comprimes-suspension-des-initiations-et-surveillance-de-la-fonction-hepatique-des-patientes-en-cours-de-traitement
2018
false
false
false
France
French
pharmacovigilance note
administration, oral
ulipristal acetate
ulipristal
continuity of patient care
drug monitoring
liver function tests
transaminases
patients guideline
guidelines for drug use
risk assessment
Chemical and Drug Induced Liver Injury
fibroid uterus
Obstetrician (occupation)
Gynecologist (occupation)
leiomyoma
norpregnadienes
---
https://www.ansm.sante.fr/actualites/actualisation-des-bonnes-pratiques-de-pharmacovigilance
2018
false
false
France
French
guideline
Drug-Related side effects and adverse reactions
product surveillance, postmarketing
adverse drug reaction reporting systems
drug monitoring
health occupations
professional role
drug approval
---
https://ansm.sante.fr/informations-de-securite/ocaliva-r-v-acide-obeticholique-renforcement-de-ladaptation-posologique-chez-les-patients-atteints-de-cholangite-biliaire-primitive-cbp-avec-insuffisance-hepatique-moderee-a-severe
2018
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
administration, oral
obeticholic acid
cholangitis
Primary cholangitis (disorder)
hepatic insufficiency
continuity of patient care
liver function tests
Hepatic decompensation
disease progression
Child-Pugh score class A (finding)
Child-Pugh score class B (finding)
Child-Pugh score class C (finding)
obeticholic acid
drug monitoring
obeticholic acid
chenodeoxycholic acid
chenodeoxycholic acid
chenodeoxycholic acid
---
https://www.who.int/hiv/pub/arv_toxicity/arv-toxicity-monitoring-tool/fr/
2018
false
false
false
product surveillance, postmarketing
drug monitoring
hiv infections
antiviral agents
data collection
Data Analysis
drug toxicity
Adverse drug reaction notification (procedure)
technical report
anti-retroviral agents
hepatitis, viral, human
Drug-Related side effects and adverse reactions
---
http://archives.uness.fr/sites/umvf/media/ressRadiologie/DESradiologie2015/03_04_2015/03_04_2015_A_Lillo_le_Louet/Index.html
http://archives.uness.fr/sites/umvf/media/ressRadiologie/DESradiologie2014/06022014/Pub_A_Lillo_le_Louet/index.htm
http://cerf.radiologie.fr/sites/cerf.radiologie.fr/files/Enseignement/DES/Archives-Documents/8%20Lillo-Le%20Lou%C3%ABt.pdf
http://cerf.radiologie.fr/sites/cerf.radiologie.fr/files/files/enseignement/pdf/10%20LL%20PV%20pdts%20contraste%209%20fev%202018.pdf
2018
false
false
false
true
France
French
audiovisual aids
pharmacovigilance
contrast media
drug monitoring
radiographic contrast media, nos
drug monitoring
---
http://www.sudoc.fr/229599613
2018
false
false
false
France
French
dissertations, academic
Physicians
Diabetes
general practice
adolescent
Adolescent
Child
Child
breast
Therapeutics
adolescence
diabetes mellitus
child
drug monitoring
Child
child, nos
education
competence
pediatrician
aptitude
association
therapeutics
Child
pediatrics
Treatments
Adolescent
competence
general practitioners
patient education as topic
Pediatricians
future
teens
education
mental competency
therapeutics
forecasting
---
https://dumas.ccsd.cnrs.fr/dumas-01896724/
2018
France
dissertations, academic
cancer care facilities
Applications
Cancer
Applications
has patient
neoplasm, malignant
patients
wrestling
registries
central
Control
cancer
Applications
pharmacovigilance
drug monitoring
wrestling
neoplasms
drug monitoring
---
https://dumas.ccsd.cnrs.fr/dumas-01901942/document
2018
France
dissertations, academic
drug monitoring
generations
antipsychotic agents
pharmacovigilance
base, nos
drug monitoring
family characteristics
---
http://www.sudoc.fr/232460345
2018
France
dissertations, academic
Perforating folliculitis
vascular medicine
thromboembolus
blood vessel, nos
pharmacovigilance
drug, nos
drug monitoring
thromboembolism
medicine
registries
Thromboembolism
Physicians
pharmaceutical preparations
causality
thromboembolism
Stress fracture
cardiology
drug monitoring
---
https://dumas.ccsd.cnrs.fr/dumas-02045859/document
2018
France
dissertations, academic
base, nos
data collection
Acute renal failure
drug monitoring
Drug-Related side effects and adverse reactions
renal insufficiency, acute
pharmacovigilance
acute renal failure syndrome, nos
renal agents
Renal failure
renal insufficiency
drug, nos
drug monitoring
acute kidney injury
---
http://www.theses.fr/2018REN1B032
2018
France
dissertations, academic
data display
drug monitoring
Big Data
Data Visualization
nursing
pharmacovigilance
massive
Data Analysis
critical pathways
drug monitoring
nursing
---
https://tel.archives-ouvertes.fr/tel-01555473
2017
false
false
false
France
French
dissertations, academic
malpractice
formed
health education
pedagogy
pharmacovigilance
drug monitoring
systemic
lacking
systems analysis
health
teaching
drug monitoring
health
---
http://www.prescrire.org/Fr/3/31/53069/0/NewsDetails.aspx
2017
false
false
false
France
French
french abstract
autoimmune disease, nos
autoimmune diseases
drug monitoring
drug, nos
---
http://pharmacovigilance-npdc.fr/breves-de-pharmacovigilance/
false
false
false
France
French
periodicals
product surveillance, postmarketing
adverse drug reaction reporting systems
drug monitoring
pharmacovigilance
drug monitoring
---
https://pharmacomedicale.org/pharmacologie/dosage-des-medicaments-suivi-therapeutique-pharmacologique
2017
false
false
false
France
French
drug information
therapeutic drug monitoring
drug, nos
pharmacologic
pharmacology
drug monitoring
---
https://extranet.chu-nice.fr/centre-pharmacovigilance/modules/smartsection/category.php?categoryid=1
false
false
false
France
French
periodicals
product surveillance, postmarketing
adverse drug reaction reporting systems
newsletters
pharmacovigilance
drug monitoring
periodicals as topic
drug monitoring
---
http://thesesante.ups-tlse.fr/1835/
2017
false
false
false
France
French
dissertations, academic
general practice
generalized
pharmacovigilance
drug monitoring
registries
drug reaction, nos
Drug-Related side effects and adverse reactions
general practitioners
reticulum
site
evaluation studies as topic
drug monitoring
---
https://www.has-sante.fr/portail/jcms/c_2774575/fr/evaluation-de-l-acte-de-recherche-ou-de-quantification-du-gene-de-fusion-bcr-abl-par-rt-pcr-dans-le-diagnostic-et-le-suivi-therapeutique-des-leucemies-myeloides-chroniques-et-des-leucemies-lymphoblastiques-aigues
2017
false
false
false
France
French
health technology assessment
leukaemia
lymphoblast
evaluation studies as topic
fusion, nos
reverse transcriptase polymerase chain reaction
precursor cell lymphoblastic Leukemia-Lymphoma
leukemia, myeloid, acute
evaluation research
drug monitoring
no diagnosis
therapeutics
chronic myeloid leukemia
gene fusion
diagnosis
genes, abl
gene, nos
leukemia, myelogenous, chronic, bcr-abl positive
therapeutics
diagnosis
---
http://www.has-sante.fr/portail/jcms/c_2752929/fr/modification-de-la-nomenclature-des-actes-de-biologie-medicale-pour-l-acte-de-suivi-therapeutique-des-patients-infectes-par-treponema-pallidum-bacterie-responsable-de-la-syphilis
2017
false
false
false
France
French
health technology assessment
patients
continuity of patient care
bacteria
altered
syphilis, nos
treponema pallidum
biologic
therapeutics
biology
syphilis
Infections
medical
bacterium, nos
drug monitoring
nomenclature
has patient
patients
bacteria
therapeutics
Infections
terminology
---
http://www.prescrire.org/Fr/3/31/53277/0/2017/ArchiveNewsDetails.aspx?page=1
2017
false
false
false
France
French
french abstract
drug monitoring
pharmacovigilance
patents as topic
eighth
drug monitoring
---
http://www.pharmacologie.u-bordeaux2.fr/fr/pharmacovigilance/INFOS/archives.htm
false
false
false
France
French
periodicals
product surveillance, postmarketing
adverse drug reaction reporting systems
pharmacovigilance
newsletters
drug monitoring
periodicals as topic
drug monitoring
---
http://thesesante.ups-tlse.fr/1873/
2017
false
false
false
France
French
dissertations, academic
data analysis
dermatologic
Drug-Related side effects and adverse reactions
antineoplastic agents
drug reaction, nos
drug monitoring
Dermatologists
pharmacovigilance
dermatology
statistics as topic
drug monitoring
---
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-05-fra.php#mise_%C3%A0_jour
2016
false
false
false
Canada
French
pharmacovigilance note
socioeconomic factors
monograph
cirrhosis of liver, nos
patients
has patient
sectional
indicators
decompensation
administration of medication, nos
effective
drug interactions
disease of liver, nos
observation
drug monitoring
pharmacovigilance
dasabuvir
contraindication to
liver cirrhosis
risk
effect modifier, epidemiologic
drug interaction
hepatic failure, nos
positive
administration
hepatic insufficiency
medication adherence
cirrhosis
monograph
indicators and reagents
observation
drug monitoring
dasabuvir
organization and administration
fibrosis
sulfonamides
uracil
---
https://www.inspq.qc.ca/toxicologie-clinique/prise-en-charge-de-la-therapie-medicamenteuse-chez-la-personne-agee-fragile
2016
false
true
false
Canada
French
journal article
drug monitoring
Frailty (finding)
drug therapy
patient care management
frail elderly
---
https://dumas.ccsd.cnrs.fr/dumas-01234961
2015
false
false
false
France
French
dissertations, academic
stroke
cerebrovascular accident, nos
hospital admission, nos
drug monitoring
pharmacovigilance
hospitalization
neurologic
stroke/cerebrovascular accident
neurology
Balance Sheet
drug monitoring
Financial Statements
---
https://www.inspq.qc.ca/toxicologie-clinique/vers-l-emergence-d-intoxications-aigues-par-la-colchicine
2015
false
true
false
Canada
French
journal article
colchicine
colchicine
colchicine
colchicine
drug monitoring
antirheumatic agents
---
https://www.jle.com/fr/revues/ito/e-docs/suivi_therapeutique_pharmacologique_des_inhibiteurs_de_proteines_kinases_305645/article.phtml
2015
false
false
false
France
French
journal article
protein kinase inhibitors
drug monitoring
dose-response relationship, drug
Precision Medicine
pharmacogenetics
protein kinase inhibitors
antineoplastic agents
antineoplastic agents
imatinib
protein-tyrosine kinases
enzyme inhibitors
enzyme inhibitors
continuity of patient care
Imatinib mesylate:MCnc:Pt:Ser/Plas:Qn:
chemistry techniques, analytical
protein kinase inhibitors
enzyme inhibitors
antineoplastic agents
Imatinib Mesylate
Imatinib Mesylate
Imatinib Mesylate
Tyrosine Kinase Inhibitors
---
https://youtu.be/qRvVQQ6ssh0
https://sesstim.univ-amu.fr/video-box/webinar-quantim-laetitia-huiart-0
2015
false
false
false
false
false
France
audiovisual aids
drug, nos
Drug-Related side effects and adverse reactions
databases, pharmaceutical
drug monitoring
health
database
database
databases, pharmaceutical
databases
---
http://www.chu-toulouse.fr/IMG/pdf/Item_181_2009_LA_PHARMACOVIGILANCE-3.pdf
2015
false
false
false
France
French
educational course
product surveillance, postmarketing
adverse drug reaction reporting systems
pharmacovigilance
drug monitoring
---
http://www.theses.fr/2015USPCS005
2015
false
true
false
France
French
dissertations, academic
epidemiological monitoring
communicable diseases
drug monitoring
---
https://www.jle.com/fr/revues/abc/e-docs/antifongiques_triazoles_interet_et_modalites_du_suivi_therapeutique_pharmacologique_et_perspectives_doptimisation_des_traitements_302259/article.phtml
10.1684/abc.2014.0968
2014
false
false
false
France
French
journal article
mycoses
immune tolerance
antifungal agents
triazoles
fluconazole
itraconazole
14-alpha demethylase inhibitors
posaconazole
Voriconazole
drug monitoring
antifungal agents
triazoles
---
https://www.inspq.qc.ca/publications/1899
https://www.inspq.qc.ca/sites/default/files/publications/1899_surveillance_resistance_antibiotiques.pdf
2014
false
false
false
Canada
French
drug resistance, bacterial
scientific and technical information
drug monitoring
government programs
epidemiological monitoring
---
http://www.revmed.ch/RMS/2014/RMS-N-434/Quelle-surveillance-medicale-des-adolescents-sous-antipsychotiques-de-deuxieme-generation
2014
false
false
false
false
Switzerland
French
antipsychotic agents
journal article
case reports
adolescent
antipsychotic agents
pregnancy
young adult
antipsychotic agents
drug monitoring
Contraindications, Procedure
Contraindications, Drug
---
https://www.revmed.ch/RMS/2014/RMS-N-416/Pourquoi-quand-et-comment-doser-les-nouveaux-anticoagulants-oraux
2014
false
false
false
Switzerland
French
journal article
thromboembolism
continuity of patient care
drug monitoring
anticoagulants
administration, oral
rivaroxaban
apixaban
dabigatran etexilate
apixaban
risk factors
blood coagulation tests
kidney failure, chronic
factor xa
antithrombins
Factor Xa Inhibitors
Rivaroxaban
Dabigatran
pyrazoles
pyridones
---
https://www.anses.fr/fr/content/bonnes-pratiques-de-pharmacovigilance
2014
false
false
false
France
French
scientific and technical information
pharmacovigilance
drug monitoring
drug monitoring
---
http://www.prescrire.org/Fr/3/31/49385/0/2014/ArchiveNewsDetails.aspx?page=1
2014
false
false
false
France
French
french abstract
europe
pharmacovigilance
drug monitoring
drug monitoring
---
http://archives.uness.fr/sites/umvf/media/ressIfsi/LimousinP3/media/MEDIA120912145849449
http://archives.uness.fr/sites/umvf/media/ressIfsi/LimousinP3/media/MEDIA120928105534225
2012
false
false
false
true
France
French
educational course
clinical
drug monitoring
therapeutics
pharmacovigilance
case study
drug monitoring
therapeutics
case reports
---
http://archives.uness.fr/sites/unf3s/media/paces/Grenoble_1112/dematteis_maurice/dematteis_maurice_p03/dematteis_maurice_p03.pdf
http://archives.uness.fr/sites/unf3s/media/paces/Grenoble_1112/dematteis_maurice/dematteis_maurice_p03/index.htm
2012
false
true
false
true
PACES / bac 1
France
French
educational course
product surveillance, postmarketing
audiovisual aids
Drug-Related side effects and adverse reactions
pharmacovigilance
drug monitoring
---
http://www.capm.ma/
Morocco
French
poison control centers
drug monitoring
---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/114000141.pdf
2011
France
French
drug industry
drug evaluation
drug monitoring
product surveillance, postmarketing
france
Drug-Related side effects and adverse reactions
organizations
professional competence
risk assessment
product surveillance, postmarketing
adverse drug reaction reporting systems
drug evaluation
technical report
---
http://archives.uness.fr/sites/umvf/media/ressMereEnfant/VAC/2011/08_jacquet/index.htm
2011
false
true
false
true
France
French
audiovisual aids
adverse drug reaction reporting systems
adverse drug reaction reporting systems
adverse drug reaction reporting systems
europe
risk management
risk management
pharmacology
france
pharmacovigilance
vaccines
drug monitoring
---
https://www.inspq.qc.ca/toxicologie-clinique/surveillance-environnementale-des-medicaments-dangereux-mise-jour-2011
2011
false
true
false
Canada
cyclophosphamide
occupational exposure
journal article
drug monitoring
environmental monitoring
---
http://campus.prescrire.org/Fr/100/320/PositionsList.aspx
2011
France
French
scientific and technical information
drug monitoring
pharmacology, clinical
Drug-Related side effects and adverse reactions
---
https://solidarites-sante.gouv.fr/IMG/pdf/Rapport_de_synthese_des_assises_du_medicament-4.pdf
2011
true
false
France
French
technical report
guidelines
product surveillance, postmarketing
drug approval
Drug-Related side effects and adverse reactions
information dissemination
pharmaceutical preparations
equipment and supplies
risk assessment
france
adverse drug reaction reporting systems
vocational education
medical order entry systems
Off-Label use
consumer health information
drug monitoring
health occupations
---
http://www.igas.gouv.fr/spip.php?article206
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/114000331.pdf
2011
France
French
technical report
guidelines
drug monitoring
adverse drug reaction reporting systems
france
---
http://www.academie-medecine.fr/11-08-securite-du-medicament-et-pharmacovigilance/
2011
false
false
France
French
guidelines
drug monitoring
---
https://medicalforum.ch/fr/detail/doi/fms.2010.07195/
2010
false
true
false
Switzerland
drug monitoring
leukemia, myeloid
Imatinib Mesylate
journal article
drug monitoring
---
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0001:0016:FR:PDF
2010
legislation
humans
drug and narcotic control
therapies, investigational
veterinarians
drug monitoring
procedures
pharmacovigilance
---
https://www.revmed.ch/RMS/2008/RMS-160/Accompagnement-therapeutique-le-chemin-du-suivi-a-long-terme
2008
false
true
false
journal article
drug monitoring
---
https://www.revmed.ch/RMS/2008/RMS-165/Suivi-therapeutique-des-medicaments-I-les-principes
2008
journal article
drug monitoring
policy
---
https://www.revmed.ch/RMS/2008/RMS-165/Suivi-therapeutique-des-medicaments-II-la-pratique-clinique1
2008
journal article
drug monitoring
---
https://www.revmed.ch/RMS/2008/RMS-170/Suivi-de-l-adhesion-therapeutique-des-patients-hypertendus-ou-dyslipidemiques-par-les-cercles-de-qualite-medecins-pharmaciens
2008
false
true
false
Switzerland
journal article
drug monitoring
physicians
management quality circles
dyslipidemias
continuity of patient care
pharmacists
patient compliance
---
http://revmed.ch/RMS/2006/RMS-67/30743
2006
Switzerland
French
psychotropic drugs
psychotropic drugs
psychotropic drugs
mental disorders
drug monitoring
journal article
consensus
table
---
http://www.ata-journal.org/articles/ata/pdf/2005/05/ata2005sup1.pdf
2005
France
journal article
toxicology
protestantism
drug monitoring
---
